AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying ...

The company has opened its Qualified Institutions Placement (QIP) issue on November 13. The floor price has been fixed at Rs ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Jefferies boosts stock price target by 54%, but the new target still implies 9% downside Tesla Inc. Chief Executive Elon Musk got what he wanted with Donald Trump's election win, now the ...

U.S. wholesale prices rose a bit faster in October and suggested that the Federal Reserve's battle to reduce inflation to low prepandemic levels may go on a while. The latest "bump" in inflation, to ...

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-based drug for cancer.

We read every day so you don't have to. Sign up for CNN Business' nightly newsletter for the top stories you need to know.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...